$ADMA Sometimes it takes a day for good news to filter through to investors.
elin246810
Posts
-
-
$ADMA I should have increased my position yesterday when it dipped to $2.48. We will be in 3’s and 4’s soon.
-
$ADMA While the trial registry page for the ongoing Phase III ITAC notes trial completion in July, a trial investigator said results should be available soon, likely in 1Q.
https://www.clinicaltrialsarena.com/comment/nihs-hivig-trial-in-hospitalised-covid-19-patients-close-to-meeting-recruitment-target-outpatient-study-planned-for-next-few-months-sources-say/ -
$ADMA is mentioned at the 29 minute mark of this Takeda/CSL conference call.
https://m.youtube.com/watch?v=6uEaA6sLUAM -
$ADMA is back in the old $2.70-$3.35 trading range.
-
$ADMA The Alliance is comprised of Takeda, Biotest, BPL, CSL Behring, LFB, Octapharma, ADMA Biologics, BioPharma Plasma, GC Pharma, Liminal BioSciences and Sanquin. The Bill & Melinda Gates Foundation is providing advisory support. Microsoft is providing technology including the Alliance website and the Plasma Bot for donor recruitment.
https://www.rockdalenewtoncitizen.com/news/plasma-therapy-manufactured-at-takeda-in-clinical-trial-as-treatment-for-covid-19-plasma-donations/article_13693780-122c-11eb-97d2-235430927359.html -
$GNUS I was considering buying this stock on all the hype but a little research changed my mind. https://www.google.com/amp/s/www.fool.com/amp/investing/2021/02/05/reasons-genius-brands-stock-crash-could-begin/
-
$ADMA
BlackRock Inc. ownership in ADMA / ADMA Biologics Inc
2021-02-02 - BlackRock Inc. has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,423,699 shares of ADMA Biologics Inc (US:ADMA). This represents 5.7 percent ownership of the company. In their previous filing dated 2020-03-09, BlackRock Inc. had reported owning 4,172,761 shares, indicating an increase of 29.98 percent. -
$ADMA “In October 2020, within the framework of the CoVIg-19 Plasma Alliance, the third phase of a clinical trial of inpatient treatment with anti-coronavirus immunoglobulin started. The results of clinical trials are planned to be published in April 2021.”
https://en.interfax.com.ua/news/general/719426.html -
ADMA$
https://www.biospace.com/article/-csl-driven-by-its-promise-to-deliver-for-covid-19-patients/
BeVard told BioSpace that the CoVIg-19 Plasma Alliance anticipates the completion of the trial during the first quarter of 2021. -
$ADMA
In this YouTube video presentation, Julie Kim of Takeda indicated at the 8 minute mark that ADMA is involved in the manufacturing of the hyperimmune globulin therapy for COVID-19 at ADMA’s facility in Florida on behalf of the CoVIg-19 Plasma Alliance!
https://m.youtube.com/watch?v=FdA2J_7cdiw -
$ADMA
Early trials of the experimental treatment indicated a 35% better chance of survival when convalescent plasma was used in "optimal patients" — which studies indicate are patients in the early stages of infection, before the virus invades the tissue and causes cell damage.
https://www.google.com/amp/s/www.cbsnews.com/amp/news/covid-convalescent-plasma-shortage/ -
$ADMA Phase 3 results should me announced any day now.
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
GNUS
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA
ADMA